SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS)

Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE)

NCT05001698 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02446899 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

NCT05835310 ·Status: RECRUITING ·Phase: PHASE3

Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

NCT04877691 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus

NCT02794285 ·Status: COMPLETED ·Phase: PHASE3

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

NCT05126277 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients

NCT02331810 ·Status: WITHDRAWN ·Phase: PHASE1

A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

NCT04895696 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations

NCT02962960 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)

NCT00298506 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus

NCT04582136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus

NCT05465707 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

NCT00429377 ·Status: COMPLETED ·Phase: PHASE3

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

NCT05648500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)

NCT06791772 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Anifrolumab Malignancy and Serious Infections Study

NCT07000110 ·Status: RECRUITING

A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis

NCT07229742 ·Status: RECRUITING ·Phase: PHASE2

Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)

NCT03878303 ·Status: UNKNOWN ·Phase: PHASE1

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

NCT01714817 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

NCT05039840 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

NCT06314282 ·Status: RECRUITING

Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus.

NCT01559090 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)

NCT01449071 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

NCT06144710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)

NCT05639114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3